Clinical Trials Directory

Trials / Completed

CompletedNCT01452425

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Université Catholique de Louvain · Academic / Other
Sex
Male
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Muscular compartment syndrome (MCS) is consecutive to an increase in intramuscular compartment pressures, and is a rare but serious postoperative complication. The INVOS (In Vivo Optical Spectroscopy) monitors tissular oxygenation continuously and non-invasively. The objective is to develop a model mimicking the physiopathology of MCS to assess the interest of the INVOS in this case.

Detailed description

After inflation of a tourniquet (pressure equal to the mean arterial pressure, we will obtain a model of slight venous congestion and arterial hypoperfusion. A comparison will be made between INVOS monitoring, sensory deficits, pain, electromyography and invasive pressure.

Conditions

Interventions

TypeNameDescription
DEVICETourniquetInflation of a tourniquet (pressure equal to the mean arterial pressure) obtaining a model of slight venous congestion and arterial hypoperfusion
DEVICEINVOS assessmentNear Infraread spectroscopy, non invasive
DEVICEEMG assessmentElectromyography, non invasive

Timeline

Start date
2011-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-10-14
Last updated
2014-12-22
Results posted
2014-12-22

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01452425. Inclusion in this directory is not an endorsement.